台股 » 個股 » 中裕 » 籌碼相關 » 主力籌碼集中度

中裕

(4147)
可現股當沖
  • 股價
    78.9
  • 漲跌
    ▼0.6
  • 漲幅
    -0.75%
  • 成交量
    435
  • 產業
    上櫃 生技醫療類股▲0.38%
  • 321人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
中裕 (4147)籌碼相關-主力籌碼集中度
籌碼集中度

市場上除了三大法人之外,有些主力大戶在買賣股票的資訊並不會被揭露,而這些主力通常卻又是影響股票價格變動的主因。當主力反覆買進/賣出某支股票,則該股籌碼集中度就會變高/變低,而通常籌碼集中度越高,越有可能出現大行情。我們將主力在券商進出的數據做出統計,給您參考!

中裕 (4147)主力籌碼與董監持股比重走勢圖

Created with Highstock 1.3.7嗨投資 histock.tw籌碼集中度外資籌碼大戶籌碼董監持股2020/04/012020/10/012021/04/012021/10/012022/04/012022/10/012023/04/012023/10/012024/04/012024/10/012025/04/010%20%40%60%
Created with Highstock 1.3.7嗨投資 histock.tw籌碼集中度收盤價2020/04/012020/10/012021/04/012021/10/012022/04/012022/10/012023/04/012023/10/012024/04/012024/10/012025/04/0140%45%50%55%60%25元50元75元100元125元150元
Created with Highstock 1.3.7嗨投資 histock.tw外資籌碼收盤價2020/04/012020/10/012021/04/012021/10/012022/04/012022/10/012023/04/012023/10/012024/04/012024/10/012025/04/016%8%10%12%25元50元75元100元125元150元
Created with Highstock 1.3.7嗨投資 histock.tw大戶籌碼收盤價2020/04/012020/10/012021/04/012021/10/012022/04/012022/10/012023/04/012023/10/012024/04/012024/10/012025/04/0130%35%40%45%50%25元50元75元100元125元150元

中裕 (4147)主力籌碼集中度 歷史資料

日期籌碼
集中度
外資
籌碼
大戶
籌碼
董監
持股
2025/05/0954.80%7.59%47.21%22.98%
2025/05/0254.54%7.61%46.93%22.98%
2025/04/2554.98%7.69%47.29%22.98%
2025/04/1855.12%7.58%47.54%22.98%
2025/04/1155.06%7.73%47.33%22.98%
2025/04/0254.98%7.72%47.26%22.98%
2025/03/2854.78%7.84%46.94%22.98%
2025/03/2154.73%7.82%46.91%22.98%
2025/03/1454.60%7.65%46.95%22.98%
2025/03/0754.64%8.30%46.34%22.98%
2025/02/2755.43%8.45%46.98%22.98%
2025/02/2155.22%8.53%46.69%22.98%
2025/02/1454.34%8.90%45.44%22.98%
2025/02/0853.67%8.13%45.54%22.98%
2025/01/2453.90%7.98%45.92%22.98%
2025/01/1754.23%8.14%46.09%22.98%
2025/01/1054.54%8.51%46.03%22.98%
2025/01/0353.09%7.89%45.20%22.98%
2024/12/2753.30%7.87%45.43%22.98%
2024/12/2053.24%7.88%45.36%22.98%
2024/12/1353.42%7.94%45.48%22.98%
2024/12/0653.05%8.15%44.90%22.98%
2024/11/2952.84%8.05%44.79%22.98%
2024/11/2252.79%7.66%45.13%22.98%
2024/11/1552.80%7.66%45.14%22.98%
2024/11/0852.31%7.53%44.78%22.98%
2024/11/0152.11%7.45%44.66%22.98%
2024/10/2552.53%7.34%45.19%22.98%
2024/10/1852.37%7.06%45.31%22.98%
2024/10/1152.36%7.04%45.32%22.98%
2024/10/0452.47%7.06%45.41%22.98%
2024/09/2752.60%7.14%45.46%22.98%
2024/09/2052.63%7.42%45.21%22.98%
2024/09/1352.75%7.43%45.32%22.98%
2024/09/0652.81%7.46%45.35%22.98%
2024/08/3052.65%7.63%45.02%22.98%
中裕首度與美國客戶簽訂CDMO合約 營運添動能Anue鉅亨-12天前
〈美對等關稅〉中裕回應暫無影響 愛滋病新藥足以供應美國市場銷售Anue鉅亨-2025/04/09
中裕長效愛滋療法主要指標達標 啟動國際授權合作Anue鉅亨-2025/03/26
中裕 相關文章